Predict your next investment

HEALTHCARE | Medical Devices & Equipment
osteotech.com

See what CB Insights has to offer

Founded Year

1986

Stage

Acq - P2P | Acquired

Valuation

$0000 

About Osteotech

Osteotech, Inc. is a global leader in the processing of human bone and connective tissue for transplantation and an innovator in the development, manufacturing and marketing of biologic, biomaterial and device systems for musculoskeletal surgery. With a particular focus on spinal, trauma, and total joint revision procedures, the Company's current and development-stage technologies address needs within numerous musculoskeletal disciplines.

Osteotech Headquarter Location

51 James Way

Eatontown, New Jersey, 07724,

United States

732-542-2800

Latest Osteotech News

StreetInsider.com - Osteotech Acquired by Medtronic for $123 Million

Jul 17, 2013

Send to a Friend Font Size: Increase Decrease Osteotech/Medtronic On August 17, 2010, Osteotech (Nasdaq: OSTE) announced an agreement to be acquired by Medtronic Inc., (NYSE: MDT) for $6.50 per share in cash, or approximately $123 million. Osteotech is a leader in the growing field of biologic products for regenerative healing, and has pioneered several innovative technology platforms including Grafton demineralized bone matrix, a family of products which has a large and growing body of evidence supporting its best-in-class bone generating capabilities.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Osteotech Patents

Osteotech has filed 12 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

12/5/2007

5/10/2011

Digestive system, Implants (medicine), Prosthetics, Orthopedic surgical procedures, Biomaterials

Grant

Application Date

12/5/2007

Grant Date

5/10/2011

Title

Related Topics

Digestive system, Implants (medicine), Prosthetics, Orthopedic surgical procedures, Biomaterials

Status

Grant

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.